Gestala Technology completes a 150-million-yuan angel round, the largest angel round in China's brain-computer interface sector | Huaxing Transaction

Follow the Huaxing Capital WeChat Official Account (ID: iChinaRenaissance) for more company information.

The first hard-tech enterprise in China focused on ultrasound brain-computer interfaces - Gestala Technology (Gestala) announces the completionUSD 15 million in angel round financing, setting a new record for the largest angel round in China’s brain-computer interface sector. This round was led byGuosheng Capital, Daotong Investmentjointly led the investment,Qingsong Capital, Gobi Ventures, Fourier Intelligence, Liepin, Yunshi Capital, and othersMultiple well-known investment institutions and enterprises participated as co-investors.Huaxing Capital served as the exclusive financial advisor.

Currently, the global brain-computer interface industry is witnessing an investment boom in the 'ultrasound track.' Notably, Sam Altman, founder of OpenAI, has personally entered the field by co-founding Merge Labs, an ultrasound-based brain-computer interface company. In January 2026, Merge Labs completed a USD 252 million angel round financing, with a post-money valuation reaching USD 850 million, led by OpenAI as the largest investor in this round. Additionally, Nudge, a company co-founded by the founder of Coinbase, secured a substantial Series A round of financing in 2025.

On January 1 this year, Gestalt Tech was jointly founded by Peng Lei, Shanda Group, and Chen Tianqiao, founder of the Tianqiao Brain Science Research Institute. Just two months after its official launch, Gestalt Tech completed a USD 15 million angel round financing, which significantly exceeded expectations, setting a new record for the highest angel round financing in China's brain-computer interface sector. Its financing scale ranks second globally only to Merge Labs.Peng Lei, Founder and CEO of Gestalt Techstated that he is highly confident in leading Gestalt Tech to become a flagship in China’s global hard technology competition and to achieve ‘parallel leadership’ in the cutting-edge ultrasound brain-computer interface sector.

Compared with traditional invasive electrical approaches, the ultrasound pathway offers advantages such as being non-invasive, enabling full-brain 'read-write' capabilities, and multi-target neural circuit modulation. The conditions it addresses—chronic pain, depression, Alzheimer's disease, Parkinson’s disease, stroke rehabilitation, and epilepsy—are more aligned with clinical needs, covering a broader patient population and offering a larger market potential.

Gestalt Tech is initially focusing on healthcare application scenarios. In the second quarter of this year, the company will complete Phase I of its headquarters and establish its first production line in Chengdu. The first-generation product will focus on chronic pain management, with over 30 clinical trials already validating its efficacy. A single stimulation can reduce pain scale scores by 50%, with effects lasting 1-2 weeks. Mass production is expected to begin in the third quarter of this year, with plans to initiate registration applications with the National Medical Products Administration (NMPA) by the end of the year. The goal is to complete registration and go to market within 1-2 years, quickly achieving revenue closure. Meanwhile, Gestalt Tech has established cooperation frameworks with top-tier hospitals such as Huashan, Huaxi, and Xiehe, conducting multi-center clinical research targeting various indications.

Peng Lei, founder and CEO of Gestalt Technologystated that the funds raised this round will be primarily allocated to the research and development of the company’s first product and early clinical trials. The focus will be on overcoming core technological challenges, advancing clinical registration, integrating AI technologies, and laying out cutting-edge technologies, all aimed at building long-term competitive advantages and solidifying the foundation for subsequent corporate growth. Gestalt Technology will adhere to its vision of 'Better Brain for Better Humanity' and is committed to establishing a brain-computer interface platform based on ultrasound, with full-brain read-and-write capabilities. This platform will not only offer innovative treatments for various neurological disorders but also aims to decode the brain and explore future pathways where brain science and artificial intelligence converge.

The successful completion of this angel funding round signifies both the capital market’s high recognition of Gestalt Technology's technological leadership, clinical implementation capabilities, and long-term value, as well as reflects the global enthusiasm and strategic prospects for the ultrasound-based brain-computer interface sector. The investment institutions and industry partners involved in this round have high expectations for the company’s development.

As one of the co-leading investors, Chengdu BioCity Equity Investment Fund Management Co., Ltd. (Guosheng Capital)stated that brain-computer interfaces are a strategically critical area in the global technology competition, and the ultrasound route offers significant advantages such as being non-invasive and enabling full-brain 'read and write' functionality. Investing in the ultrasound brain-computer interface sector aims to seize the high ground of future industries, ensuring that our country has independent influence in the next generation of human-computer interaction technologies, transitioning from 'following' to 'leading.' As the location of Gestalt Technology’s headquarters, Chengdu Tianfu International BioCity expressed forward-looking support and strong backing for future industries like brain-computer interfaces, providing comprehensive, lifecycle-wide empowerment through financial support, industrial resource alignment, scientific research cooperation, and policy adaptation. This will help accelerate the company's core technology breakthroughs and clinical trial progress, pushing ultrasound brain-computer interface technology from the lab to clinical implementation. Additionally, using Gestalt Technology as a benchmark, it will attract upstream and downstream enterprises to gather in Chengdu, fostering a nationally influential ultrasound brain-computer interface industrial cluster.

As one of the co-leading investors and earliest institutional investors, DaoTong InvestmentWe remain strongly optimistic about the ultrasound brain-computer interface technology route, viewing it as another highly promising direction beyond electrical brain-computer interfaces, with notable advantages such as being non-invasive, enabling full-brain read-write capabilities, and high spatiotemporal resolution. It is expected to achieve breakthroughs in the healthcare field first and points towards the ultimate future of 'carbon-based and silicon-based intelligence fusion' in the long term. Gestalt Technology possesses deep technological accumulation and solid, efficient transformation and implementation capabilities. We firmly believe in its long-term value and look forward to collaborating with the Gestalt Technology team to promote the implementation of a new generation of brain-computer interface interaction paradigms.

QingSong Capitalstated that as a professional investment institution in the medical field, we have long been focused on innovative opportunities in neuromodulation and brain-computer interfaces. Gestalt has quickly built an interdisciplinary team specialized in ultrasonic brain-computer interfaces and established a closed-loop of foundational capabilities. Leveraging our professional understanding of brain science and medical device industries, we will provide targeted support in core technologies and clinical applications, helping the company achieve continuous breakthroughs in the ultrasound BCI track.

Gobi Venturesstated that Gestalt Technology is a typical practice of Gobi Ventures’ patient capital philosophy. The company has established a 'full-coverage, multi-dimensional brain modulation' technology system centered around ultrasound neuromodulation, setting a benchmark in the brain-computer interface field for 'frontier innovation + high safety,' and opening new avenues for precise intervention and treatment across various neurological indications. We are genuinely delighted to partner with Gestalt Technology and will leverage Hong Kong’s international advantages to assist in expanding into the Asian and global markets, promoting this disruptive technology to benefit more patients.

Liepinstated that they will continue to be optimistic about Gestalt Technology's next-generation BCI technology route of 'ultrasound + AI', helping brain-computer interfaces achieve a key leap from cutting-edge research to commercial implementation, and look forward to it becoming the global leader in the ultrasound BCI field.

Cloud Time Capitalstated that in the diversified development landscape of brain-computer interfaces, the ultrasound solution combines high resolution with high safety, making it a highly promising direction. The Gestalt Technology team possesses both research depth and industry vision; we firmly believe they can become leaders in this field, driving brain science achievements from the lab to the broader market.

with a strategic partnership with Gestalt TechnologyEmbodied Intelligence Company Fourieralso participated in this round of financing as an investor and expressed anticipation of collaborating with Gestalt Technology to explore innovative applications combining brain-computer interfaces with embodied intelligence, particularly in the medical rehabilitation field. Together, they aim to build a closed-loop training mechanism of 'intent-execution-perceptual feedback', achieving a transition from passive function compensation to active intention-driven control, advancing rehabilitation paradigm shifts, and potentially providing more efficient and safer solutions for stroke rehabilitation patients, disabled populations, etc.

with research collaboration with Gestalt TechnologyTianfu Jincheng Laboratory (Frontier Medical Center)stated that they have jointly built a brain and neuromorphic laboratory with Gestalt Technology. Both parties are systematically advancing key technology R&D and achievement transformation around the core technical direction of ultrasonic brain-computer interfaces, further deepening cooperation in scientific research, pipeline R&D, equity investment, and other aspects.

Qin Chuan, Business Partner of Huaxing Capital's Investment Banking Divisionstated that we are honored to assist Gestalt Technology in completing this round of financing. As a leading domestic hardcore technology enterprise focused on ultrasonic brain-computer interfaces, the Gestalt team has demonstrated top-tier research vision and industrial implementation capabilities. The company focuses on the non-invasive ultrasound technology route, possessing unique advantages of precise penetration and multi-target regulation. Its first product targeting chronic pain has received preliminary clinical validation, demonstrating significant clinical value. We firmly believe that Gestalt Technology will take this financing as an opportunity to accelerate core technology breakthroughs and clinical implementation, bringing safer and more accessible treatment options for brain diseases to patients worldwide, and growing into a global leading force driving innovation in the brain-computer interface industry.

Wang Lixing, CEO of Huaxing Capitalexpressed congratulations to Gestalt for completing this round of financing. Ultrasonic brain-computer interfaces are becoming a forefront in global technological competition, and we are honored to assist the leading company in this field with its financing. The Gestalt team demonstrated rare strategic resolve and execution capabilities from its inception, making precise choices in technology routes and pursuing clinical value relentlessly, which has enabled the company to quickly establish a solid first-mover advantage. We believe that as non-invasive technologies continue to make breakthroughs in the treatment of brain diseases, Gestalt Technology is poised to become a key driver in this cross-disciplinary industry. Huaxing Capital will continue to support the company's growth into a hard-tech enterprise with global influence.

Disclaimer: This article is authorized for republication by Gestalt Technology and is intended solely for readers' reference. It should not be regarded as a research report on any securities in any region, nor does it constitute an invitation or guarantee for the purchase, subscription of securities, or other financial instruments and products. Readers should not rely solely on this article but should make investment decisions based on their own judgment and seek professional advice before taking any investment actions. Huaxing Capital makes no representations or warranties regarding the content of this article and assumes no responsibility for any consequences arising from the use, misuse, reliance, distribution, or possession of this article.

16K Views